AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Tracking every penny for budgeting provides clarity and control over finances. This intro highlights the benefits and sets you up for smarter spending.
26,876 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
In 2026, a wave of AI-powered tools is reshaping how agents manage leads, websites, and transactions as the market sh...
A wave of AI-related investment, pegged at $750 billion, is reshaping expectations for NVIDIA, Alphabet, and Oracle a...
As the 2026 World Cup unfolds, France stands to collect a sizable prize pot regardless of results. Meanwhile, Mbappé ...
Founders Fund has fully exited ETHZilla, and Peter Thiel has followed with a complete stake unload, underscoring a br...
Mortgage lenders must navigate two major credit scores under a framework of automated underwriting in 2026. Critics s...
In 2026, the equal-weight S&P 500 index has posted impressive breadth-driven gains, outpacing the cap-weight S&P 500 ...
Loan brokerages are expanding headcount and GCI, but margins are thinning. A new industry look shows why growth often...
AI-driven infrastructure growth is lifting semiconductor ETFs and a broad set of chipmakers. The wave is broadening b...
Apple reveals a staggering pay gap in its 2025 proxy, with CEO compensation at roughly $74 million vs. a median emplo...
Squid Crypto raised $6 million with Ripple backing, only to see $3 million drained in a 24-hour window as a periphera...
Nvidia faces a pivotal test in 2029 as AI demand continues to power growth, but regulatory hurdles and supply constra...